{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T13:43:53Z","timestamp":1762177433026,"version":"3.37.3"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,8,4]],"date-time":"2021-08-04T00:00:00Z","timestamp":1628035200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,8,4]],"date-time":"2021-08-04T00:00:00Z","timestamp":1628035200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["#81572783","#81974438"],"award-info":[{"award-number":["#81572783","#81974438"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Cell Int"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Altered Plastin-3 (PLS3; an actin-binding protein) expression was associated with human carcinogenesis, including pancreatic ductal adenocarcinoma (PDA). This study first assessed differentially expressed genes (DEGs) and then bioinformatically and experimentally confirmed PLS3 to be able to predict PDA prognosis and distinguish PDA from diffuse large B-cell lymphoma.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This study screened multiple online databases and revealed DEGs among PDA, normal pancreas, diffuse large B-cell lymphoma (DLBCL), and normal lymph node tissues and then focused on PLS3. These DEGs were analyzed for Gene Ontology (GO) terms, Kaplan\u2013Meier curves, and the log-rank test to characterize their association with PDA prognosis. The receiver operating characteristic curve (ROC) was plotted, and Spearman\u2019s tests were performed. Differential PLS3 expression in different tissue specimens (n\u2009=\u200930) was evaluated by reverse transcription quantitative polymerase chain reaction (RT-qPCR).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>There were a great number of DEGs between PDA and lymph node, between PDA and DLBCL, and between PDA and normal pancreatic tissues. Five DEGs (NET1, KCNK1, MAL2, PLS1, and PLS3) were associated with poor overall survival of PDA patients, but only PLS3 was further verified by the R2 and ICGC datasets. The ROC analysis showed a high PLS3 AUC (area under the curve) value for PDA diagnosis, while PLS3 was able to distinguish PDA from DLBCL. The results of Spearman's analysis showed that PLS3 expression was associated with levels of KRT7, SPP1, and SPARC. Differential PLS3 expression in different tissue specimens was further validated by RT-qPCR.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Altered PLS3 expression was useful in diagnosis and prognosis of PDA as well as to distinguish PDA from DLBCL.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12935-021-02117-1","type":"journal-article","created":{"date-parts":[[2021,8,4]],"date-time":"2021-08-04T09:03:05Z","timestamp":1628067785000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Plastin-3 is a diagnostic and prognostic marker for pancreatic adenocarcinoma and distinguishes from diffuse large B-cell lymphoma"],"prefix":"10.1186","volume":"21","author":[{"given":"Fei","family":"Xiong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guan-Hua","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4846-1220","authenticated-orcid":false,"given":"Yong-Jun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,8,4]]},"reference":[{"key":"2117_CR1","first-page":"367","volume-title":"Pancreatic cancer, world cancer report: cancer research for cancer prevention","author":"C Wild","year":"2020","unstructured":"Wild C, Weiderpass E, Stewart BW. Pancreatic cancer, world cancer report: cancer research for cancer prevention. Lyon: World Health Organization; 2020. p. 367\u201373."},{"key":"2117_CR2","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","volume":"74","author":"L Rahib","year":"2014","unstructured":"Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, Matrisian LM. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 2014;74:2913\u201321.","journal-title":"Cancer Res"},{"key":"2117_CR3","doi-asserted-by":"publisher","first-page":"318","DOI":"10.3322\/caac.21190","volume":"63","author":"CL Wolfgang","year":"2013","unstructured":"Wolfgang CL, Herman JM, Laheru DA, Klein AP, Erdek MA, Fishman EK, et al. Recent progress in pancreatic cancer. CA Cancer J Clin. 2013;63:318\u201348.","journal-title":"CA Cancer J Clin"},{"key":"2117_CR4","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/S0140-6736(10)62307-0","volume":"378","author":"A Vincent","year":"2011","unstructured":"Vincent A, Herman J, Schulick R, Hruban RH, Goggins M. Pancreatic cancer. Lancet. 2011;378:607\u201320.","journal-title":"Lancet"},{"key":"2117_CR5","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0140-6736(16)00141-0","volume":"388","author":"T Kamisawa","year":"2016","unstructured":"Kamisawa T, Wood LD, Itoi T, Takaori K. Pancreatic cancer. Lancet. 2016;388:73\u201385.","journal-title":"Lancet"},{"key":"2117_CR6","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1158\/1541-7786.MCR-19-0490","volume":"18","author":"G Urrutia","year":"2020","unstructured":"Urrutia G, Salmonson A, Toro-Zapata J, de Assuncao TM, Mathison A, Dusetti N, et al. Combined targeting of g9a and checkpoint kinase 1 synergistically inhibits pancreatic cancer cell growth by replication fork collapse. Mol Cancer Res. 2020;18:448\u201362.","journal-title":"Mol Cancer Res"},{"key":"2117_CR7","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1097\/COC.0000000000000544","volume":"42","author":"D Mukhija","year":"2019","unstructured":"Mukhija D, Nagpal SJS, Sohal DPS. Epidemiology, tumor characteristics, and survival in patients with primary pancreatic lymphoma: a large population-based study using the seer database. Am J Clin Oncol. 2019;42:454\u20138.","journal-title":"Am J Clin Oncol"},{"key":"2117_CR8","doi-asserted-by":"publisher","first-page":"4467","DOI":"10.3748\/wjg.v23.i24.4467","volume":"23","author":"SM Zheng","year":"2017","unstructured":"Zheng SM, Zhou DJ, Chen YH, Jiang R, Wang YX, Zhang Y, et al. Pancreatic T\/histiocyte-rich large B-cell lymphoma: a case report and review of literature. World J Gastroenterol. 2017;23:4467\u201372.","journal-title":"World J Gastroenterol"},{"key":"2117_CR9","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1245\/s10434-014-4176-6","volume":"22","author":"E Sadot","year":"2015","unstructured":"Sadot E, Yahalom J, Do RK, Teruya-Feldstein J, Allen PJ, Gonen M, et al. Clinical features and outcome of primary pancreatic lymphoma. Ann Surg Oncol. 2015;22:1176\u201384.","journal-title":"Ann Surg Oncol"},{"key":"2117_CR10","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1055\/s-0029-1243859","volume":"42","author":"M Khashab","year":"2010","unstructured":"Khashab M, Mokadem M, DeWitt J, Emerson R, Sherman S, LeBlanc J, et al. Endoscopic ultrasound-guided fine-needle aspiration with or without flow cytometry for the diagnosis of primary pancreatic lymphoma\u2014a case series. Endoscopy. 2010;42:228\u201331.","journal-title":"Endoscopy"},{"key":"2117_CR11","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/dc.24349","volume":"48","author":"O Savari","year":"2020","unstructured":"Savari O, Al-Duwal Z, Wang Z, Ganesan S, Danan-Rayes R, Ayub S. Pancreatic lymphoma: a cytologic diagnosis challenge. Diagn Cytopathol. 2020;48:350\u20135.","journal-title":"Diagn Cytopathol"},{"key":"2117_CR12","doi-asserted-by":"publisher","first-page":"e189","DOI":"10.1016\/j.acra.2018.07.021","volume":"26","author":"Z Huang","year":"2019","unstructured":"Huang Z, Li M, He D, Wei Y, Yu H, Wang Y, et al. Two-dimensional texture analysis based on CT images to differentiate pancreatic lymphoma and pancreatic adenocarcinoma: a preliminary study. Acad Radiol. 2019;26:e189\u201395.","journal-title":"Acad Radiol"},{"key":"2117_CR13","first-page":"2393","volume":"17","author":"J Kurashige","year":"2019","unstructured":"Kurashige J, Yokobori T, Mima K, Sawada G, Takahashi Y, Ueo H, et al. Plastin3 is associated with epithelial\u2013mesenchymal transition and poor prognosis in gastric cancer. Oncol Lett. 2019;17:2393\u20139.","journal-title":"Oncol Lett"},{"issue":"11","key":"2117_CR14","doi-asserted-by":"publisher","first-page":"8416","DOI":"10.1002\/jcp.29685","volume":"235","author":"Z Xin","year":"2020","unstructured":"Xin Z, Li D, Mao F, Du Y, Wang X, Xu P, et al. PLS3 predicts poor prognosis in pancreatic cancer and promotes cancer cell proliferation via PI3K\/AKT signaling. J Cell Physiol. 2020;235(11):8416\u201323.","journal-title":"J Cell Physiol"},{"key":"2117_CR15","first-page":"59","volume":"87","author":"R Kujawski","year":"2015","unstructured":"Kujawski R, Przyby\u0142owska-Sygut K, Mik M, Lewandowski M, Trzci\u0144ski R, Berut M, et al. Expression of the pls3 gene in circulating cells in patients with colorectal cancer. Pol Przegl Chir. 2015;87:59\u201364.","journal-title":"Pol Przegl Chir"},{"key":"2117_CR16","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.3390\/cancers11111663","volume":"11","author":"A Velthaus","year":"2019","unstructured":"Velthaus A, Cornils K, Hennigs JK, Grub S, Stamm H, Wicklein D, et al. The actin binding protein plastin-3 is involved in the pathogenesis of acute myeloid leukemia. Cancers. 2019;11:1663.","journal-title":"Cancers"},{"key":"2117_CR17","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1038\/bjc.2015.132","volume":"112","author":"H Ueo","year":"2015","unstructured":"Ueo H, Sugimachi K, Gorges TM, Bartkowiak K, Yokobori T, Muller V, et al. Circulating tumour cell-derived plastin3 is a novel marker for predicting long-term prognosis in patients with breast cancer. Br J Cancer. 2015;112:1519\u201326.","journal-title":"Br J Cancer"},{"key":"2117_CR18","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1158\/0008-5472.CAN-12-0326","volume":"73","author":"T Yokobori","year":"2013","unstructured":"Yokobori T, Iinuma H, Shimamura T, Imoto S, Sugimachi K, Ishii H, et al. Plastin3 is a novel marker for circulating tumor cells undergoing the epithelial\u2013mesenchymal transition and is associated with colorectal cancer prognosis. Cancer Res. 2013;73:2059\u201369.","journal-title":"Cancer Res"},{"key":"2117_CR19","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1007\/s13277-013-0754-7","volume":"34","author":"J Szkandera","year":"2013","unstructured":"Szkandera J, Winder T, Stotz M, Weissmueller M, Langsenlehner T, Pichler M, et al. A common gene variant in PLS3 predicts colon cancer recurrence in women. Tumour Biol. 2013;34:2183\u20138.","journal-title":"Tumour Biol"},{"key":"2117_CR20","doi-asserted-by":"publisher","first-page":"D560","DOI":"10.1093\/nar\/gkv1337","volume":"44","author":"YD Shaul","year":"2016","unstructured":"Shaul YD, Yuan B, Thiru P, Nutter-Upham A, McCallum S, Lanzkron C, et al. MERAV: a tool for comparing gene expression across human tissues and cell types. Nucleic Acids Res. 2016;44:D560\u20136.","journal-title":"Nucleic Acids Res"},{"key":"2117_CR21","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43:e47.","journal-title":"Nucleic Acids Res"},{"key":"2117_CR22","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1093\/bioinformatics\/bts034","volume":"28","author":"JT Leek","year":"2012","unstructured":"Leek JT, Johnson WE, Parker HS, Jaffe AE, Storey JD. The sva package for removing batch effects and other unwanted variation in high-throughput experiments. Bioinformatics. 2012;28:882\u20133.","journal-title":"Bioinformatics"},{"key":"2117_CR23","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16:284\u20137.","journal-title":"OMICS"},{"key":"2117_CR24","doi-asserted-by":"publisher","first-page":"2912","DOI":"10.1093\/bioinformatics\/btv300","volume":"31","author":"W Walter","year":"2015","unstructured":"Walter W, Sanchez-Cabo F, Ricote M. GOplot: an R package for visually combining expression data with functional analysis. Bioinformatics. 2015;31:2912\u20134.","journal-title":"Bioinformatics"},{"key":"2117_CR25","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nature16965","volume":"531","author":"P Bailey","year":"2016","unstructured":"Bailey P, Chang DK, Nones K, Johns AL, Patch AM, Gingras MC, et al. Genomic analyses identify molecular subtypes of pancreatic cancer. Nature. 2016;531:47\u201352.","journal-title":"Nature"},{"key":"2117_CR26","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/1471-2105-12-77","volume":"12","author":"X Robin","year":"2011","unstructured":"Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez JC, et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinform. 2011;12:77.","journal-title":"BMC Bioinform"},{"key":"2117_CR27","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1097\/01.pas.0000149710.01559.fe","volume":"29","author":"JL Hornick","year":"2005","unstructured":"Hornick JL, Lauwers GY, Odze RD. Immunohistochemistry can help distinguish metastatic pancreatic adenocarcinomas from bile duct adenomas and hamartomas of the liver. Am J Surg Pathol. 2005;29:381\u20139.","journal-title":"Am J Surg Pathol"},{"key":"2117_CR28","doi-asserted-by":"publisher","first-page":"5037","DOI":"10.2147\/OTT.S206039","volume":"12","author":"Z Huo","year":"2019","unstructured":"Huo Z, Zhai S, Weng Y, Qian H, Tang X, Shi Y, et al. PRPF40A as a potential diagnostic and prognostic marker is upregulated in pancreatic cancer tissues and cell lines: an integrated bioinformatics data analysis. Onco Targets Ther. 2019;12:5037\u201351.","journal-title":"Onco Targets Ther"},{"key":"2117_CR29","doi-asserted-by":"publisher","first-page":"390","DOI":"10.12998\/wjcc.v8.i2.390","volume":"8","author":"YY Ma","year":"2020","unstructured":"Ma YY, Shi JJ, Chen JB, Xu KC, Niu LZ. Irreversible electroporation for liver metastasis from pancreatic cancer: a case report. World J Clin Cases. 2020;8:390\u20137.","journal-title":"World J Clin Cases"},{"key":"2117_CR30","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/S0169-5002(03)00229-0","volume":"41","author":"A Fritscher-Ravens","year":"2003","unstructured":"Fritscher-Ravens A. Endoscopic ultrasound evaluation in the diagnosis and staging of lung cancer. Lung Cancer. 2003;41:259\u201367.","journal-title":"Lung Cancer"},{"key":"2117_CR31","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aah5583","author":"J Kim","year":"2017","unstructured":"Kim J, Bamlet WR, Oberg AL, Chaffee KG, Donahue G, Cao XJ, et al. Detection of early pancreatic ductal adenocarcinoma with thrombospondin-2 and CA19\u20139 blood markers. Sci Transl Med. 2017. https:\/\/doi.org\/10.1126\/scitranslmed.aah5583.","journal-title":"Sci Transl Med"},{"key":"2117_CR32","doi-asserted-by":"publisher","first-page":"10202","DOI":"10.1073\/pnas.1704961114","volume":"114","author":"JD Cohen","year":"2017","unstructured":"Cohen JD, Javed AA, Thoburn C, Wong F, Tie J, Gibbs P, et al. Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers. Proc Natl Acad Sci USA. 2017;114:10202\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2117_CR33","doi-asserted-by":"publisher","first-page":"2887","DOI":"10.1200\/JCO.2017.77.6658","volume":"36","author":"LD Mellby","year":"2018","unstructured":"Mellby LD, Nyberg AP, Johansen JS, Wingren C, Nordestgaard BG, Bojesen SE, et al. Serum biomarker signature-based liquid biopsy for diagnosis of early-stage pancreatic cancer. J Clin Oncol. 2018;36:2887\u201394.","journal-title":"J Clin Oncol"},{"key":"2117_CR34","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1136\/gutjnl-2016-312580","volume":"67","author":"X Fan","year":"2018","unstructured":"Fan X, Alekseyenko AV, Wu J, Peters BA, Jacobs EJ, Gapstur SM, et al. Human oral microbiome and prospective risk for pancreatic cancer: a population-based nested case\u2013control study. Gut. 2018;67:120\u20137.","journal-title":"Gut"},{"key":"2117_CR35","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1053\/j.gastro.2018.04.025","volume":"155","author":"A Sharma","year":"2018","unstructured":"Sharma A, Smyrk TC, Levy MJ, Topazian MA, Chari ST. Fasting blood glucose levels provide estimate of duration and progression of pancreatic cancer before diagnosis. Gastroenterology. 2018;155:490-500.e2.","journal-title":"Gastroenterology"},{"key":"2117_CR36","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1053\/j.gastro.2018.05.023","volume":"155","author":"A Sharma","year":"2018","unstructured":"Sharma A, Kandlakunta H, Nagpal SJS, Feng Z, Hoos W, Petersen GM, et al. Model to determine risk of pancreatic cancer in patients with new-onset diabetes. Gastroenterology. 2018;155:730-739.e3.","journal-title":"Gastroenterology"},{"key":"2117_CR37","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1056\/NEJMra1404198","volume":"371","author":"DP Ryan","year":"2014","unstructured":"Ryan DP, Hong TS, Bardeesy N. Pancreatic adenocarcinoma. New Engl J Med. 2014;371:1039\u201349.","journal-title":"New Engl J Med"},{"key":"2117_CR38","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1177\/1066896918810866","volume":"27","author":"D Yau","year":"2019","unstructured":"Yau D, Aron M, Siddiqi IN. Diffuse large B-cell lymphoma with striking intrasinusoidal pseudoglandular growth pattern as a diagnostic dilemma mimicking metastatic poorly differentiated pancreatic adenocarcinoma in an intraabdominal lymph node. Int J Surg Pathol. 2019;27:181\u20134.","journal-title":"Int J Surg Pathol"},{"key":"2117_CR39","first-page":"392","volume":"44","author":"A Constantin","year":"2018","unstructured":"Constantin A, T\u0103nase AD, S\u0103ftoiu A, Cop\u0103escu C. A primary retroperitoneal diffuse large b-cell lymphoma: a challenging diagnosis. Curr Health Sci J. 2018;44:392\u20136.","journal-title":"Curr Health Sci J"},{"key":"2117_CR40","first-page":"pd09","volume":"11","author":"B Ravindhran","year":"2017","unstructured":"Ravindhran B, Prakash C, Govindharaj S, Bahnou NMS, Pavithra B. An aggressive primary retroperitoneal diffuse large B-cell lymphoma mimicking a pancreatic neoplasm, presenting as duodenal stenosis. J Clin Diagn Res. 2017;11:pd09-pd11.","journal-title":"J Clin Diagn Res"},{"key":"2117_CR41","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1159\/000086539","volume":"5","author":"D Neureiter","year":"2005","unstructured":"Neureiter D, Zopf S, Dimmler A, Stintzing S, Hahn EG, Kirchner T, et al. Different capabilities of morphological pattern formation and its association with the expression of differentiation markers in a xenograft model of human pancreatic cancer cell lines. Pancreatology. 2005;5:387\u201397.","journal-title":"Pancreatology"},{"key":"2117_CR42","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.3390\/ijms18071556","volume":"18","author":"CH Chang","year":"2017","unstructured":"Chang CH, Yen MC, Liao SH, Hsu YL, Lai CS, Chang KP, et al. Secreted protein acidic and rich in cysteine (SPARC) enhances cell proliferation, migration, and epithelial mesenchymal transition, and SPARC expression is associated with tumor grade in head and neck cancer. Int J Mol Sci. 2017;18:1556.","journal-title":"Int J Mol Sci"},{"key":"2117_CR43","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1002\/hep.29669","volume":"67","author":"S Wan","year":"2018","unstructured":"Wan S, Meyer AS, Weiler SME, Rupp C, Toth M, Sticht C, et al. Cytoplasmic localization of the cell polarity factor scribble supports liver tumor formation and tumor cell invasiveness. Hepatology. 2018;67:1842\u201356.","journal-title":"Hepatology"},{"key":"2117_CR44","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1002\/biof.1442","volume":"44","author":"W Sun","year":"2018","unstructured":"Sun W, Feng J, Yi Q, Xu X, Chen Y, Tang L. SPARC acts as a mediator of TGF-beta1 in promoting epithelial-to-mesenchymal transition in A549 and H1299 lung cancer cells. BioFactors. 2018;44:453\u201364.","journal-title":"BioFactors"},{"key":"2117_CR45","doi-asserted-by":"publisher","first-page":"18587","DOI":"10.1002\/jcp.28497","volume":"234","author":"SZ Song","year":"2019","unstructured":"Song SZ, Lin S, Liu JN, Zhang MB, Du YT, Zhang DD, et al. Targeting of SPP1 by microRNA-340 inhibits gastric cancer cell epithelial\u2013mesenchymal transition through inhibition of the PI3K\/AKT signaling pathway. J Cell Physiol. 2019;234:18587\u2013601.","journal-title":"J Cell Physiol"},{"key":"2117_CR46","doi-asserted-by":"publisher","first-page":"9640","DOI":"10.1021\/acs.analchem.9b01061","volume":"91","author":"F Shi","year":"2019","unstructured":"Shi F, Ma Y, Qian Y, Wang Y, Wang Z, Zhao M, et al. A novel peptide probe for identification of PLS3-expressed cancer cells. Anal Chem. 2019;91:9640\u20137.","journal-title":"Anal Chem"},{"key":"2117_CR47","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3390\/cancers11010059","volume":"11","author":"A Markiewicz","year":"2019","unstructured":"Markiewicz A, Topa J, Nagel A, Skokowski J, Seroczynska B, Stokowy T, et al. Spectrum of epithelial\u2013mesenchymal transition phenotypes in circulating tumour cells from early breast cancer patients. Cancers. 2019;11:59.","journal-title":"Cancers"}],"container-title":["Cancer Cell International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-021-02117-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12935-021-02117-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-021-02117-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,4]],"date-time":"2021-08-04T13:04:26Z","timestamp":1628082266000},"score":1,"resource":{"primary":{"URL":"https:\/\/cancerci.biomedcentral.com\/articles\/10.1186\/s12935-021-02117-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,4]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2117"],"URL":"https:\/\/doi.org\/10.1186\/s12935-021-02117-1","relation":{},"ISSN":["1475-2867"],"issn-type":[{"type":"electronic","value":"1475-2867"}],"subject":[],"published":{"date-parts":[[2021,8,4]]},"assertion":[{"value":"6 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The experimental protocol was established according to the ethical guidelines of the Helsinki Declaration and approved by the Ethics Committee of Tongji Hospital. All data published here is under the consent for publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that there is no conflict of interest in this work.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"411"}}